Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis
- 30 September 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 94 (3) , 458-464
- https://doi.org/10.1016/0091-6749(94)90201-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Precision of conjunctival provocation tests in right and left eyesJournal of Allergy and Clinical Immunology, 1993
- Effects of Vasocon-A in the Allergen Challenge Model of Acute Allergic ConjunctivitisArchives of Ophthalmology (1950), 1990
- Conjunctival Allergen ChallengeArchives of Ophthalmology (1950), 1990
- CONJUNCTIVAL PROVOCATION TESTS AND NATURALLY OCCURRING ALLERGIC CONJUNCTIVITIS IN CLINICAL TRIALSInternational Ophthalmology Clinics, 1988
- Effect of a New Selective H1 Receptor Antagonist (Levocabastine) in a Nasal and Conjunctival Provocation TestInternational Archives of Allergy and Immunology, 1987
- Oral antiallergic activity in ascaris hypersensitive dogs: A study of known antihistamines and of the new compounds ramastine (R 57 959) and levocabastine (R 50 547)Drug Development Research, 1986
- Cross‐reactivity between deciduous trees during immunotherapy. I. In vivo resultsClinical and Experimental Allergy, 1986
- Production of Leukotrienes in Human Skin and Conjunctival Mucosa after Specific Allergen ChallengeAllergy, 1985
- The Precision of the Conjunctival Provocation TestAllergy, 1984
- Topical ocular administration of cromolyn sodium for treatment in seasonal ragweed conjunctivitisJournal of Allergy and Clinical Immunology, 1979